Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amplify Debuts New Weight Loss Drug ETF By: ETF Trends May 21, 2024 at 14:17 PM EDT On Tuesday, Amplify entered the weight loss ETF space with the launch of the Amplify Weight Loss Drug & Treatment ETF (THNR). THNR operates with a net expense ratio of 0.59%. Additionally, the fund aims to provide investors with results similar to the performance of the VettaFi Weight Loss Drug & Treatment Index (THINR). THINR [...] The post Amplify Debuts New Weight Loss Drug ETF appeared first on ETF Trends . Read More >> Related Stocks: THNR Yieldshares Cwp Dividend & Option Income Amplify Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Amplify Debuts New Weight Loss Drug ETF By: ETF Trends May 21, 2024 at 14:17 PM EDT On Tuesday, Amplify entered the weight loss ETF space with the launch of the Amplify Weight Loss Drug & Treatment ETF (THNR). THNR operates with a net expense ratio of 0.59%. Additionally, the fund aims to provide investors with results similar to the performance of the VettaFi Weight Loss Drug & Treatment Index (THINR). THINR [...] The post Amplify Debuts New Weight Loss Drug ETF appeared first on ETF Trends . Read More >> Related Stocks: THNR Yieldshares Cwp Dividend & Option Income Amplify